Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lasser

Showing results (201-210 of 222) with videos related to

Pageof 23
Sort By:
Gastroenterologie Clinique Et Biologique|March 3, 1999
[What are the real indications for hepatectomies in metastases of colorectal origin?]D Elias, M Ducreux, P Rougier, et al.
Annals of Surgical Oncology|November 1, 1995
Prognostic factors in resectable gastric cancer: results of EORTC study no. 40813 on FAM adjuvant chemotherapyM Lise, D Nitti, A Marchet, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 6, 2008
The differential response to chemotherapy of ovarian metastases from colorectal carcinomaD Goéré, C Daveau, D Elias, et al.
Pathologie-Biologie|October 1, 1990
Radioimmunotherapy of colon carcinoma with I-131 labeled antibodies, successful experimental results and clinical dosimetry studyJ P Mach, F Buchegger, A Pelegrin, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Potential contribution of 131I-labelled monoclonal anti-CEA antibodies in the treatment of liver metastases from colorectal carcinomas: pretherapeutic study with dose recovery in resected tissuesM Ychou, M Ricard, J Lumbroso, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 1, 1992
Polyadenylic-polyuridylic acid as an adjuvant in resectable colorectal carcinoma: a 6 1/2 year follow-up analysis of a multicentric double blind randomized trialJ Lacour, A Laplanche, M Malafosse, et al.
Journal of the American College of Surgeons|October 1, 1995
Phase I-II randomized study on prehepatectomy recombinant interleukin-2 immunotherapy in patients with metastatic carcinoma of the colon and rectumD Elias, F Farace, F Triebel, et al.
Presse Medicale (Paris, France : 1983)|May 27, 1995
[Treatment of metastatic malignant insulinomas. 2 cases]L Mounedji-Boudiaf, P Rougier, S Culine, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1990
[Primitive digestive localizations of malignant non-Hodgkin's lymphoma. Prognostic factors of locally advanced disease: stage II. Report of 67 cases]P Rougier, M Azab, M Henry-Amar, et al.
The British Journal of Surgery|August 1, 1986
Conservative management of breast cancerD Sarrazin, J A Dewar, R Arriagada, et al.
Pageof 23

Showing results (201-210 of 222) with videos related to

Sort By:
Pageof 23
Gastroenterologie Clinique Et Biologique|March 3, 1999
[What are the real indications for hepatectomies in metastases of colorectal origin?]D Elias, M Ducreux, P Rougier, et al.
Annals of Surgical Oncology|November 1, 1995
Prognostic factors in resectable gastric cancer: results of EORTC study no. 40813 on FAM adjuvant chemotherapyM Lise, D Nitti, A Marchet, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 6, 2008
The differential response to chemotherapy of ovarian metastases from colorectal carcinomaD Goéré, C Daveau, D Elias, et al.
Pathologie-Biologie|October 1, 1990
Radioimmunotherapy of colon carcinoma with I-131 labeled antibodies, successful experimental results and clinical dosimetry studyJ P Mach, F Buchegger, A Pelegrin, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Potential contribution of 131I-labelled monoclonal anti-CEA antibodies in the treatment of liver metastases from colorectal carcinomas: pretherapeutic study with dose recovery in resected tissuesM Ychou, M Ricard, J Lumbroso, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 1, 1992
Polyadenylic-polyuridylic acid as an adjuvant in resectable colorectal carcinoma: a 6 1/2 year follow-up analysis of a multicentric double blind randomized trialJ Lacour, A Laplanche, M Malafosse, et al.
Journal of the American College of Surgeons|October 1, 1995
Phase I-II randomized study on prehepatectomy recombinant interleukin-2 immunotherapy in patients with metastatic carcinoma of the colon and rectumD Elias, F Farace, F Triebel, et al.
Presse Medicale (Paris, France : 1983)|May 27, 1995
[Treatment of metastatic malignant insulinomas. 2 cases]L Mounedji-Boudiaf, P Rougier, S Culine, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1990
[Primitive digestive localizations of malignant non-Hodgkin's lymphoma. Prognostic factors of locally advanced disease: stage II. Report of 67 cases]P Rougier, M Azab, M Henry-Amar, et al.
The British Journal of Surgery|August 1, 1986
Conservative management of breast cancerD Sarrazin, J A Dewar, R Arriagada, et al.
Pageof 23